Private Advisor Group LLC Lowers Position in Tilray Inc (NASDAQ:TLRY)

Private Advisor Group LLC reduced its holdings in shares of Tilray Inc (NASDAQ:TLRY) by 4.3% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 177,293 shares of the company’s stock after selling 7,912 shares during the quarter. Private Advisor Group LLC’s holdings in Tilray were worth $312,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the business. Tidal Investments LLC lifted its position in shares of Tilray by 36,687.0% during the first quarter. Tidal Investments LLC now owns 10,677,428 shares of the company’s stock worth $26,373,000 after purchasing an additional 10,648,403 shares in the last quarter. Bank of Montreal Can raised its holdings in Tilray by 19.6% in the second quarter. Bank of Montreal Can now owns 2,169,100 shares of the company’s stock valued at $3,622,000 after acquiring an additional 355,778 shares in the last quarter. Virtu Financial LLC acquired a new stake in Tilray in the first quarter valued at $586,000. Mirae Asset Global Investments Co. Ltd. raised its holdings in Tilray by 8.7% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 2,679,532 shares of the company’s stock valued at $6,699,000 after acquiring an additional 213,834 shares in the last quarter. Finally, J.W. Cole Advisors Inc. raised its holdings in Tilray by 1,077.2% in the second quarter. J.W. Cole Advisors Inc. now owns 171,054 shares of the company’s stock valued at $284,000 after acquiring an additional 156,524 shares in the last quarter. 9.35% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Separately, Roth Mkm dropped their target price on shares of Tilray from $2.00 to $1.75 and set a “neutral” rating on the stock in a report on Friday, October 11th.

Tilray Stock Performance

Shares of TLRY opened at $1.54 on Thursday. The firm has a market capitalization of $1.39 billion, a PE ratio of -5.70 and a beta of 2.14. The company has a quick ratio of 1.57, a current ratio of 2.47 and a debt-to-equity ratio of 0.08. The firm has a 50-day moving average price of $1.68 and a 200 day moving average price of $1.79. Tilray Inc has a 52-week low of $1.45 and a 52-week high of $2.97.

Tilray (NASDAQ:TLRY) last released its earnings results on Thursday, October 10th. The company reported ($0.04) EPS for the quarter, meeting the consensus estimate of ($0.04). The firm had revenue of $200.00 million for the quarter, compared to analysts’ expectations of $218.70 million. Tilray had a negative net margin of 26.79% and a negative return on equity of 2.00%. Tilray’s quarterly revenue was up 13.0% on a year-over-year basis. During the same quarter last year, the company earned ($0.10) EPS. On average, sell-side analysts anticipate that Tilray Inc will post -0.14 earnings per share for the current fiscal year.

Tilray Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.